The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 7 years. This subset of the different portfolios I regularly analyze has now exceeded 260 weeks of public selections as part of this ongoing live forward-testing research. The frequency of 10%+ returns in a week is averaging over 4x the broad market averages in the past 5+ years.
In 2017, the sample size began with 12 stocks, then 8 stocks in 2018, and at members' request since 2020, I now generate only 4 selections each week. In addition 2 Dow 30 picks are provided, as well as a new active ETF portfolio that competes against a signal ETF model. Monthly Growth & Dividend MDA breakout stocks continue to beat the market each year as well. I offer 11 top models of short and long term value and momentum portfolios that have beaten the S&P 500 since my trading studies were made public.
The cumulative average weekly breakout returns for 2022 is up to +80.4% not using the gauge signal. Officially, for trading signals, we have had only 2 weeks of a positive signals in 2022 with the worst 5 month start to the stock market since 1973. We are in unusual markets ahead of QT in June: "A good review of bear market bounces $SPY #SPX 2022 / 2008 overlay as #QT begins. Watch for strong confirmation of negative channel breakouts. Not all bounces are a bottom."
In a quick study of the MDA breakout selections YTD, there are 69 picks in 24 weeks beating the S&P 500. 42 picks are beating the S&P 500 by over 10% and as high as +84.7% (TDW), +56.8% (RES), +46.6% (MNRL), +22.9% (ESTE), +16.6% (TMST), +26.1% (EGY) and +16.3% (NE) significantly beating the major indices YTD.
Additional background, measurements, and high frequency breakout records on the Weekly MDA Breakout model is here.
Returns from 21 Weeks of Positive Momentum Gauge signals in 2021
Last year there were only 21 positive trading weeks to achieve +70.5% returns. For 2022 the market has been even worse with only two official positive weekly signal on the Momentum Gauges® so far despite strong returns in many negative market weeks.
Momentum Gauge® trading signal: Negative conditions ahead of Week 25
Weekly return measurements into the 2nd quarter of 2022.
Red weekly color indicates negative Market Momentum Gauge signals. MDA breakout selections outperform when the market signal is positive and daily negative values are below 40 level.
Historical MDA Breakout minimal buy/hold returns are at +70.5% YTD when trading only in the positive weeks consistent with the positive Momentum Gauges® signals. Remarkably, the frequency streak of 10% gainers within a 4- or 5-day trading week continues at highly statistically significant levels above 80% not counting frequent multiple 10%+ gainers in a single week.
Longer term many of these selections join the V&M Multibagger list now at 86 weekly picks with over 100%+ gains, 39 picks over 200%+, 13 picks over 500%+ and 6 picks with over 1000%+ gains since January 2019 such as:
More than 200 stocks have gained over 10% in a 5-day trading week since this MDA testing began in 2017. A frequency comparison chart is at the end of this article. Readers are cautioned that these are highly volatile stocks that may not be appropriate for achieving your long term investment goals: How to Achieve Optimal Asset Allocation
The Momentum Gauge® conditions continue with highly negative warning signals with only two full weeks of positive conditions back in Week 12 and 22 of 2022 with returns of +1.19% following the signals and avoiding the worst 5 month market start since 1973.
The Breakout Picks are high volatility selections for high short-term gains, but with no selections below $2/share, under 100k average daily volume, or less than $100 million market cap. Prior returns are documented here.
2022 marks the worst 100 day start to the stock market since 1939 and the Momentum Gauge® MDA buy signals continue negative ahead of next week.
Why not avoid all the major market downturns? It is best to follow the signals as the Federal Reserve's Quantitative Tightening program is scheduled to begin in June.
All the Momentum Gauge® charts are available this week in a special update report.
All the momentum signals are negative through last week on declining momentum conditions. Performance of all the portfolios are greatly enhanced by following the signals.
The picks for next week consist of 1 Technology, 1 Consumer Cyclical, and 2 Healthcare sector stocks. These stocks are released to members in advance every Friday morning near the open. Prior selections may be doing well, but for research purposes I deliberately do not duplicate selections from the prior week. These selections are based on MDA characteristics from my research, including strong money flows, positive sentiment, and strong fundamentals -- but readers are cautioned to follow the Momentum Gauges® for the best results.
Arbutus Biopharma Corp - Healthcare / Biotechnology
Price Target: $3.50/share (See my FAQ #20 on price targets)
|Jun-08-22 02:05AM||Arbutus to Present Seven Scientific Posters at EASL International Liver Congress 2022 GlobeNewswire|
|Jun-06-22 02:45PM||We Think Arbutus Biopharma Can Easily Afford To Drive Business Growth Simply Wall St.|
|Jun-06-22 07:32AM||Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus GlobeNewswire|
|Jun-06-22 07:30AM||Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus GlobeNewswire|
|Jun-02-22 07:30AM||Arbutus to Participate in June Investor Conferences GlobeNewswire|
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication.
Source: Company resources
Full Truck Alliance - Technology / Software - Application
Price Target: $12.00/share (See my FAQ #20 on price targets)
|Jun-10-22 03:00PM||Full Truck Alliance Co. Ltd. Q1 2022 Earnings Call Transcript Motley Fool|
|Jun-10-22 10:05AM||Why DiDi Global, Full Truck Alliance, and Kanzhun Skyrocketed This Week Motley Fool|
|Jun-08-22 11:02AM||Why Shares of JD.com, Alibaba, and Full Truck Alliance Are Rising Today Motley Fool|
|Jun-08-22 04:00AM||Full Truck Alliance Co. Ltd. Announces First Quarter 2022 Unaudited Financial Results PR Newswire|
|Jun-06-22 01:00PM||China to Wrap Probe Into Didi as Soon as This Week, WSJ Says Bloomberg|
Full Truck Alliance Co. Ltd., together with its subsidiaries, operates a digital freight platform that connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types in the People's Republic of China. The company offers freight listing, matching, and brokerage services; and online transaction services, as well as various value-added services, such as credit solutions, insurance brokerage, electronic toll collection, and energy services.
Source: Company resources
First, be sure to follow the Momentum Gauges® when applying the same MDA breakout model parameters to only 30 stocks on the Dow Index. Conditions and signals remain very negative in the worst start of the stock year since 1973 and last week was the worst week since March 2020. Second, these selections are made without regard to market cap or the below-average volatility typical of mega-cap stocks that may produce good results relative to other Dow 30 stocks.
The most recent picks of weekly Dow selections in pairs for the last 5 weeks:
|Symbol||Company||Current % return from selection Week|
|(IBM)||International Business Machines||-4.84%|
|(MRK)||Merck & Co.||-5.82%|
If you are looking for a much broader selection of mega-cap breakout stocks beyond just 30 Dow stocks with more detailed analysis and strong returns, I would recommend the Growth & Dividend MDA Breakout picks.
These selections are significantly outperforming major hedge funds and all the hedge fund averages since inception. Consider the actively managed ARK Innovation fund down -58.98% YTD and more hedge funds liquidating in 2022.
These picks are released monthly for long term total return with strong returns that are leading the S&P 500 by +12.90% through 2022. As members know all the portfolio returns are substantially improved by following the Momentum Gauges® signal. All of the 1 and 2-year returns of monthly portfolios are beating the major market indices YTD are shown below -- without including additional returns from large dividends over +2% for each stock:
Coca-Cola Co. (KO)
Coca-Cola is a strong defensive sector stock with nearly 3% dividend yield that was among the few Dow stocks improving on Friday. Institutions are net buyers in the current quarter but insiders are large percentage sellers with indicators negative and showing only slight improvement in the negative channel. Analysts still maintain a consensus target of $69/share with no particular time horizon as usual.
As I have documented before from my research over the years, these MDA breakout picks were designed as high frequency gainers.
These documented high frequency gains in less than a week continue into 2020 at rates more than four times higher than the average stock market returns against comparable stocks with a minimum $2/share and $100 million market cap. The enhanced gains from further MDA research in 2020 are both larger and more frequent than in previous years in every category. ~ The 2020 MDA Breakout Report Card
The frequency percentages remain very similar to returns documented here on Seeking Alpha since 2017 and at rates that greatly exceed the gains of market returns by 2x and as much as 5x in the case of 5% gains.
The 2021 and 2020 breakout percentages with 4 stocks selected each week.
MDA selections are restricted to stocks above $2/share, $100M market cap, and greater than 100k avg daily volume. Penny stocks well below these minimum levels have been shown to benefit greatly from the model but introduce much more risk and may be distorted by inflows from readers selecting the same micro-cap stocks.
These stocks continue the live forward-testing of the breakout selection algorithms from my doctoral research with continuous enhancements over prior years. These Weekly Breakout picks consist of the shortest duration picks of seven quantitative models I publish from top financial research that also include one-year buy/hold value stocks. Remember to follow the Momentum Gauges® in your investing decisions for the best results.
All the V&M portfolio models are beating the market indices in the worst 100 day start to the US stock market since 1939 and the worst 5 month start since 1973. The new active ETF portfolio is up +31.80% YTD beating the S&P 500 by over +54.7% YTD. The Top ETF returns in the Momentum Gauge® signal from June 10th are DRIP +52.1%, ERY +42%, and SOXS +27.3% shown below:
The final 2021 returns for the different portfolio models from January of last year are shown below.
All the very best to you, stay safe and healthy and have a great week of trading!
JD Henning, PhD, MBA, CFE, CAMS
If you are looking for a great community to apply proven financial models with picks ranging from short term breakouts to long term value and forensic selections, join our 1,200+ outstanding members at Value & Momentum Breakouts
See what members are saying now - Click HERE
This article was written by
Welcome! I am a Finance PhD, MBA, investment adviser, fraud examiner and certified anti-money laundering specialist with more than 30 years trading and investing stocks and other securities. I'm the founder of Value & Momentum Breakouts.
I'm JD Henning, the founder of Value & Momentum Breakouts. I've spent decades studying how to get better returns in the market. I've earned degrees researching markets, and even more importantly, I've spent the time myself as a trader and investor. I am one of those unusual multi-millionaire, PhD's in finance, former Coast Guard officer with a bunch of certifications ranging from anti-money laundering specialist, investment adviser, to fraud examiner... who genuinely enjoys helping others do well in the markets. I'm bringing the fruits of my experience and research to this service. I am highly accessible to members to answer questions and give guidance.
It's been quite the start of the year for investors. My guess is, after a decade of good times in the market, you’re here looking for some guidance in how to navigate these volatile markets and the uncertainty of the coronavirus and inflationary conditions. You’re in the right place. For the past 5 years I’ve made my trading systems public and helped hundreds of my subscribers navigate and profit from every market downturn and breakout - including the coronavirus crash last year.
Value & Momentum Breakouts doesn't stop with the Momentum Gauges® and the Bull/Bear ETF strategy. The service is designed for investors who appreciate having easy access to quick picks from many top quantitative financial models across different types of investing strategies. Portfolios and selections cover all types of investments:
Commodity and Volatility fund trading
Cryptocurrency chart analysis
Long term high-dividend growth stocks
Short term high-frequency breakout stocks
Forensic analysis value stocks
Value enhanced long term growth picks
ETF sector and bull/bear combination trades
Dow mega cap breakout picks
Sector and Index Momentum Gauges® for market timing
I share my expertise by generating frequent Value & Momentum Breakout stock portfolios from the different financial algorithms across peer-reviewed financial literature. The best selection of stocks from these algorithms are applied to the Premium Portfolio, beating the S&P 500 for the 3rd straight year in a row with average annual gains of 32.98% through 2020.
Try a 2-Week FREE trial and see all the value for yourself.
Disclosure: I/we have a beneficial long position in the shares of KOLD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure: I continue to follow the Market Momentum Gauge® and Sector Momentum Gauge® signals. I adjust my exposure ahead of weekends and holidays to minimize the risk from these high volatility 3x funds that may not be appropriate investments for your portfolio. Readers are highly encouraged to consider your own optimal asset allocation strategies to diversify risks and enhance returns. I am mostly in cash this year with the Weekly Gauges negative 26 out of the last 31 weeks from the November topping signal.